Nature of the anti-Xa activity induced by a heparin analogue (SSHA) in vivo.
D000925:Anticoagulants / Q000494:pharmacology*; D000990:Antithrombin III / Q000378:metabolism; D001780:Blood Coagulation Tests; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000494:pharmacology*; D005170:Factor X / Q000032:analysis / Q000037:antagonists & inhibitors*; D015951:Factor Xa; D006801:Humans; D007163:Immunosorbent Techniques; D010314:Partial Thromboplastin Time; D011479:Protamines / Q000494:pharmacology
D000925:Anticoagulants; D011479:Protamines; C026210:SSHA; D000990:Antithrombin III; D005170:Factor X; D002807:Chondroitin; D002809:Chondroitin Sulfates; D015951:Factor Xa